Literature DB >> 6387047

Inactivation of neurotensin by rat brain synaptic membranes. Cleavage at the Pro10-Tyr11 bond by endopeptidase 24.11 (enkephalinase) and a peptidase different from proline-endopeptidase.

F Checler, P C Emson, J P Vincent, P Kitabgi.   

Abstract

UNLABELLED: It was shown previously that the tridecapeptide neurotensin is inactivated by rat brain synaptic membranes and that one of the primary inactivating cleavages occurs at the Pro10-Try11 peptide bond, leading to the formation of NT1-10 and NT11-13. The present study was designed to investigate the possibility that this cleavage was catalyzed by proline endopeptidase and/or endopeptidase 24.11 (enkephalinase). Purified rat brain synaptic membranes were found to contain a N-benzyloxycarbonyl-Gly-Pro-4-methyl-coumarinyl-7-amide-hydrolyzin g activity that was markedly inhibited (93%) by the proline endopeptidase inhibitor N-benzyloxycarbonyl-Pro-Prolinal and partially blocked (25%) by an antiproline endopeptidase antiserum. In contrast, the cleavage of neurotensin at the Pro10-Tyr11 bond by synaptic membranes was not affected by N-benzyloxycarbonyl-Pro-Prolinal and the antiserum. When the conversion of NT1-10 to NT1-8 by angiotensin converting enzyme was blocked by captopril and when the processing of NT11-13 by aminopeptidase(s) was inhibited by bestatin, it was found that thiorphan, a potent endopeptidase 24.11 inhibitor, partially decreased the formation of NT1-10 and NT11-13 by synaptic membranes. IN
CONCLUSION: (1) proline endopeptidase, although it is present in synaptic membranes, is not involved in the cleavage of neurotensin at the Pro10-Tyr11 bond; (2) endopeptidase 24.11 only partially contributes to this cleavage; (3) there exists in rat brain synaptic membranes a peptidase different from proline endopeptidase and endopeptidase 24.11 that is mainly responsible for inactivating neurotensin by cleaving at the Pro10-Tyr11 bond.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6387047     DOI: 10.1111/j.1471-4159.1984.tb05386.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Tissue distribution of a novel neurotensin-degrading metallopeptidase. An immunological approach using monospecific polyclonal antibodies.

Authors:  F Checler; H Barelli; J P Vincent
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

2.  Fluorimetric assay of the neurotensin-degrading metalloendopeptidase, endopeptidase 24.16.

Authors:  P Dauch; H Barelli; J P Vincent; F Checler
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

Review 3.  Neurolysin: From Initial Detection to Latest Advances.

Authors:  Frédéric Checler; Emer S Ferro
Journal:  Neurochem Res       Date:  2018-08-29       Impact factor: 3.996

4.  Neurolysin knockout mice generation and initial phenotype characterization.

Authors:  Diogo M L P Cavalcanti; Leandro M Castro; José C Rosa Neto; Marilia Seelaender; Rodrigo X Neves; Vitor Oliveira; Fábio L Forti; Leo K Iwai; Fabio C Gozzo; Mihail Todiras; Ines Schadock; Carlos C Barros; Michael Bader; Emer S Ferro
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

5.  Purification and properties of a neurotensin-degrading endopeptidase from pig brain.

Authors:  P E Millican; A J Kenny; A J Turner
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

6.  Rational redesign of neutral endopeptidase binding to merlin and moesin proteins.

Authors:  Masha Y Niv; Katsuyuki Iida; Rong Zheng; Akio Horiguchi; Ruoqian Shen; David M Nanus
Journal:  Protein Sci       Date:  2009-05       Impact factor: 6.725

7.  Phosphorus-containing peptides as mixed inhibitors of endopeptidase 3.4.24.15 and 3.4.24.16: effect on neurotensin degradation in vitro and in vivo.

Authors:  B Vincent; V Dive; A Yiotakis; C Smadja; R Maldonado; J P Vincent; F Checler
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

8.  The anti-apoptotic role of neurotensin.

Authors:  Christelle Devader; Sophie Béraud-Dufour; Thierry Coppola; Jean Mazella
Journal:  Cells       Date:  2013-03-04       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.